News / 1 February 2007
 

 

 2007/OB/04

OXFORD BIOMEDICA EXTRAORDINARY GENERAL MEETING

Oxford, UK - 1 February 2007: Oxford BioMedica (LSE: OXB), the leading gene therapy company, announced today that all resolutions were duly passed at the Extraordinary General Meeting, held today in London.

- ends -
 

Return to the News

Notes

For further information please contact:

 

Oxford BioMedica plc
Professor Alan Kingsman, Chief Executive

Tel: +44 (0)1865 783 000

City/Financial Enquiries
Lisa Baderoon/Mark Court/Mary-Jane Johnson
Buchanan Communications

Tel: +44 (0)20 7466 5000

Scientific/Trade Press Enquiries
Katja Stout/Gemma Price
College Hill - Life Sciences		 Tel: +44 (0)20 3008 7550

Top of page

Website by College Hill - Life Sciences
 
   2008 
   Archive
   2007 
   2006 
   2005 
   2004 
   2003 
   2002 
   2001
   2000
   1999
   1998
   1997
 
Email Alerts
Enter your email address to be kept informed of news updates

Unsubscribe
Enter your email address to be removed from our mailing list